Olema Pharmaceuticals, Inc.
OLMA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001750284
In the last 90 days, Olema Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 185 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; Duquesne Family Office is the only superinvestor holding it.
13F holders, Q1 2024
Institutional positions in Olema Pharmaceuticals, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 126
- +13 vs. Q4 2023
- Shares held
- 56.1M
- +4.49M (+8.7%) vs. Q4 2023
- Total value
- $635.2M
- −$81.9M (−11.4%) vs. Q4 2023
- New holders
- 30
- 40 more added
- Sold out
- 17
- 35 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OLMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 185 | $1.28B |
| Q1 2026 | 195 | $1.51B |
| Q4 2025 | 200 | $2.27B |
| Q3 2025 | 126 | $668.2M |
| Q2 2025 | 123 | $300.5M |
| Q1 2025 | 134 | $248.0M |
| Q4 2024 | 157 | $415.4M |
| Q3 2024 | 130 | $700.3M |
| Q2 2024 | 129 | $626.9M |
| Q1 2024 | 126 | $635.2M |
| Q4 2023 | 113 | $717.1M |
| Q3 2023 | 97 | $584.4M |
| Q2 2023 | 87 | $329.2M |
| Q1 2023 | 66 | $116.1M |
| Q4 2022 | 67 | $81.6M |
| Q3 2022 | 73 | $92.1M |
| Q2 2022 | 76 | $139.2M |
| Q1 2022 | 91 | $155.2M |
| Q4 2021 | 97 | $359.5M |
| Q3 2021 | 76 | $1.01B |
| Q2 2021 | 69 | $1.05B |
| Q1 2021 | 74 | $1.16B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Olema Pharmaceuticals, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Goldman Sachs Group Inc | 437,031 | $4.95M | 0.00% | +121,553+38.5% | Added |
| Adage Capital Partners GP, L.L.C. | 460,000 | $5.21M | 0.01% | −40,000−8.0% | Reduced |
| Morgan Stanley | 498,126 | $5.64M | 0.00% | +282+0.1% | Added |
| Silverarc Capital Management, LLC | 515,317 | $5.83M | 1.64% | −58,513−10.2% | Reduced |
| Marshall Wace, LLP | 547,803 | $6.20M | 0.01% | +257,082+88.4% | Added |
| Ally Bridge Group (NY) LLC | 559,035 | $6.33M | 3.52% | −100,000−15.2% | Reduced |
| Altium Capital Management LP | 605,000 | $6.85M | 3.06% | +191,393+46.3% | Added |
| Victory Capital Management Inc | 610,649 | $6.91M | 0.01% | −10,878−1.8% | Reduced |
| Soleus Capital Management, L.P. | 658,000 | $7.45M | 0.65% | +658,000 | New |
| Braidwell LP | 704,344 | $7.97M | 0.26% | +704,344 | New |
| Polar Capital Holdings Plc | 750,000 | $8.49M | 0.05% | 00.0% | Unchanged |
| Woodline Partners LP | 750,279 | $8.49M | 0.08% | 00.0% | Unchanged |
| Citadel Advisors LLC | 780,660 | $8.84M | 0.01% | +496,708+174.9% | Added |
| Wellington Management Group LLP | 835,613 | $9.46M | 0.00% | +736,200+740.5% | Added |
| Geode Capital Management, LLC | 839,345 | $9.50M | 0.00% | +14,512+1.8% | Added |
| Janus Henderson Group PLC | 1,221,662 | $13.8M | 0.01% | +521,562+74.5% | Added |
| Vivo Capital, LLC | 1,873,704 | $21.2M | 1.67% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 1,936,157 | $21.9M | 0.01% | +220,737+12.9% | Added |
| MPM Oncology Impact Management LP | 1,953,690 | $22.1M | 3.56% | +96,554+5.2% | Added |
| Vanguard Group Inc | 2,407,688 | $27.3M | 0.00% | −298,207−11.0% | Reduced |
| State Street Corp | 3,178,427 | $36.0M | 0.00% | +2,505,257+372.2% | Added |
| BlackRock Inc. | 3,216,554 | $36.4M | 0.00% | −47,353−1.5% | Reduced |
| Deep Track Capital, LP | 3,225,419 | $36.5M | 1.05% | +1,294,525+67.0% | Added |
| Logos Global Management LP | 4,383,875 | $49.6M | 5.22% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 7,903,600 | $89.5M | 3.15% | 00.0% | Unchanged |
| BVF Inc | 9,135,893 | $103.4M | 2.84% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −2,456,800−100.0% | Sold out |
| First Light Asset Management, LLC | 0 | $0 | 0.00% | −631,064−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −539,831−100.0% | Sold out |
| Kingdon Capital Management, L.L.C. | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −281,287−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −228,139−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −173,611−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −50,766−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −39,584−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −35,989−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −27,462−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −25,913−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −19,866−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −15,874−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −11,319−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −2,193−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |